Genzyme Expands Framingham Campus
Cambridge-based biotech and pharmaceuticals giant Genzyme Corp. has expanded its presence in Framingham with the lease of nearly 136,000 square feet at the 9/90 Corporate Center.
The company now occupies more than 1.2 million square feet in Framingham at the Framingham Technology Park and 9/90 Corporate Center, which is near the intersection of Route 9 and Interstate 90, just east of Interstate 495.
The company already occupied 26,000 square feet at 200 Crossing Blvd. in the complex and expanded to 80,000 square feet there. The company also leased a 55,000-square-foot building at 200 Staples Drive, according to CB Richard Ellis, the Boston-based commercial real estate broker that represented Genzyme in the deal.
The lease was signed in mid-December.
The complex's landlord is National Development and UBS Realty Investors, which were represented by FHO Partners of Boston in the deal.
WBJ Web Partners
Most Recent
Most Recent
0 Comments